Regulatory Affairs for Advanced Therapies
Regulatory strategy (EU, US, UK)
Scientific advice meetings & briefing packages
Orphan drug designations, PRIME, RMAT, ATMP classificationst itemst item
Authoring support
Module 3 authoring (IMPD, MAA, IND, BLA)
Preparation for scientific advice meetings & briefing packages
Writing Module 3 summaries and strategy documents for life cycle maintenance
Project Management
Subcontracting network management
Outsourced regulatory operations
Custom Solutions
Flexible arrangements (ad-hoc consulting, interim support, long-term partnerships).